Consistently, activating HIF-1 by pretreatment with pharmacological PHDs inhibitors such as cobalt and FG-4592 significantly attenuated cisplatin-induced AKI by inhibiting mitochondrial signaling pathways and upregulating HIF target genes [22,115]. This evidence concerns the gene HIF1A and acute kidney injury.